Last update: July 2017 Luspatercept A novel agent that increases haemoglobin by promoting erythropoiesis. More specifically it promotes the differentiation and maturation of late-stage erythrocyte precursors by acting as a ligand trap for members of the TGF-β superfamily, the increased signaling of which inhibits erythrocyte maturation. This mechanism of action ...